Works matching IS 03065251 AND DT 2023 AND VI 89 AND IP 7
Results: 44
Issue Highlights.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1913, doi. 10.1111/bcp.15812
- By:
- Publication type:
- Article
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco‐toxicological data to assess and potentially mitigate their diffusion to water supplies.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2020, doi. 10.1111/bcp.15761
- By:
- Publication type:
- Article
Risk of infection from glucocorticoid and methotrexate interaction in patients with rheumatoid arthritis using biologics: A retrospective cohort study.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2168, doi. 10.1111/bcp.15687
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacokinetic/pharmacodynamic characterization of the dolutegravir/rilpivirine two‐drug regimen in SWORD‐1/‐2 phase 3 studies.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2190, doi. 10.1111/bcp.15683
- By:
- Publication type:
- Article
BC Clinical impact of medication reviews with follow‐up in cardiovascular older patients in primary care: A cluster‐randomized controlled trial.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2131, doi. 10.1111/bcp.15682
- By:
- Publication type:
- Article
A case series of bacillus Calmette‐Guérin scar reactivation after administration of both mRNA and viral vector COVID‐19 vaccines.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2113, doi. 10.1111/bcp.15678
- By:
- Publication type:
- Article
Evaluation of the inhibitory effects of itraconazole on letermovir.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2122, doi. 10.1111/bcp.15677
- By:
- Publication type:
- Article
Polypharmacy and associated cumulative anticholinergic burden are important predictors of falls risk.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2332, doi. 10.1111/bcp.15753
- By:
- Publication type:
- Article
Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2039, doi. 10.1111/bcp.15751
- By:
- Publication type:
- Article
Patterns of antiseizure medications prescribing in people with intellectual disability and epilepsy: A narrative review and analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2028, doi. 10.1111/bcp.15748
- By:
- Publication type:
- Article
Ensovibep, a SARS‐CoV‐2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first‐in‐human, ascending single‐dose Phase 1 study.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2295, doi. 10.1111/bcp.15747
- By:
- Publication type:
- Article
Clinically relevant bidirectional drug‐drug interaction between midostaurin and voriconazole.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2304, doi. 10.1111/bcp.15743
- By:
- Publication type:
- Article
Physiology‐based pharmacokinetic modelling and experimental data suggest that rifabutin alters dolutegravir kinetics by both P‐glycoprotein induction and concurrent inhibition.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2329, doi. 10.1111/bcp.15740
- By:
- Publication type:
- Article
Medication adherence research comes of age.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1914, doi. 10.1111/bcp.15722
- By:
- Publication type:
- Article
Prescribing of low‐dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2263, doi. 10.1111/bcp.15708
- By:
- Publication type:
- Article
Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels: A study based on therapeutic drug monitoring data.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2246, doi. 10.1111/bcp.15706
- By:
- Publication type:
- Article
Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2283, doi. 10.1111/bcp.15702
- By:
- Publication type:
- Article
Cannabidiol–drug interaction in cancer patients: A retrospective study in a real‐life setting.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2322, doi. 10.1111/bcp.15701
- By:
- Publication type:
- Article
Dostarlimab, an anti‐programmed death‐1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration‐QT analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2272, doi. 10.1111/bcp.15700
- By:
- Publication type:
- Article
Open‐label, drug–drug interaction study between the HIV‐1 maturation inhibitor GSK3640254 and a metabolic probe cocktail in healthy participants.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2236, doi. 10.1111/bcp.15699
- By:
- Publication type:
- Article
Anticholinergic burden in middle and older age is associated with lower cognitive function, but not with brain atrophy.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2224, doi. 10.1111/bcp.15698
- By:
- Publication type:
- Article
Population pharmacokinetics of amikacin in suspected cases of neonatal sepsis.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2254, doi. 10.1111/bcp.15697
- By:
- Publication type:
- Article
Derivation and validation of a risk prediction score for nonsteroidal anti‐inflammatory drug‐related serious gastrointestinal complications in the elderly.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2216, doi. 10.1111/bcp.15696
- By:
- Publication type:
- Article
Evaluation of the effect of ritlecitinib on the pharmacokinetics of caffeine in healthy participants.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2208, doi. 10.1111/bcp.15695
- By:
- Publication type:
- Article
Differences in the location of bleeding with direct oral anticoagulants vs. vitamin K antagonists: A study in the World Health Organization's pharmacovigilance database.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2201, doi. 10.1111/bcp.15693
- By:
- Publication type:
- Article
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2316, doi. 10.1111/bcp.15692
- By:
- Publication type:
- Article
Colchicine enhances β adrenoceptor‐mediated vasodilation in men with essential hypertension.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2179, doi. 10.1111/bcp.15688
- By:
- Publication type:
- Article
Preventive effect of dexamethasone premedication on the development of infusion‐related reaction in breast cancer patients receiving trastuzumab.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2102, doi. 10.1111/bcp.15675
- By:
- Publication type:
- Article
Question‐based development of high‐risk medical devices: A proposal for a structured design and review process.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2144, doi. 10.1111/bcp.15685
- By:
- Publication type:
- Article
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2309, doi. 10.1111/bcp.15684
- By:
- Publication type:
- Article
A phase I, single‐sequence, open‐label study to evaluate the drug–drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2160, doi. 10.1111/bcp.15664
- By:
- Publication type:
- Article
A population pharmacokinetic–pharmacodynamic model evaluating efficacy of nalbuphine extended‐release in patients with prurigo nodularis.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2088, doi. 10.1111/bcp.15663
- By:
- Publication type:
- Article
Optimizing adherence to allopurinol for gout: patients' perspectives.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1978, doi. 10.1111/bcp.15657
- By:
- Publication type:
- Article
An allopurinol adherence tool using plasma oxypurinol concentrations.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1956, doi. 10.1111/bcp.15516
- By:
- Publication type:
- Article
Examining nonadherence in the treatment of tuberculosis: The patterns that lead to failure.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1965, doi. 10.1111/bcp.15515
- By:
- Publication type:
- Article
Estimation of adherence to medication treatment in presence of censoring.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1928, doi. 10.1111/bcp.15452
- By:
- Publication type:
- Article
Scalability of effective adherence interventions for patients using cardiovascular disease medication: A realist synthesis‐inspired systematic review.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1996, doi. 10.1111/bcp.15418
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1911, doi. 10.1111/bcp.15402
- Publication type:
- Article
Partnership between patients and interprofessional healthcare providers along the multifaceted journey to medication adherence.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1992, doi. 10.1111/bcp.15325
- By:
- Publication type:
- Article
Methodological considerations on estimating medication adherence from self‐report, electronic monitoring and electronic healthcare databases using the TEOS framework.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1918, doi. 10.1111/bcp.15375
- By:
- Publication type:
- Article
A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4‐inhibitor drugs; a multistate transition model.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2076, doi. 10.1111/bcp.15373
- By:
- Publication type:
- Article
Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testing.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1938, doi. 10.1111/bcp.15318
- By:
- Publication type:
- Article
How to handle a delayed or missed dose of edoxaban in patients with non‐valvular atrial fibrillation? A model‐informed remedial strategy.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2066, doi. 10.1111/bcp.15316
- By:
- Publication type:
- Article
Major disparities in patient‐reported adherence compared to objective assessment of adherence using mass spectrometry: A prospective study in a tertiary‐referral hypertension clinic.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1948, doi. 10.1111/bcp.15292
- By:
- Publication type:
- Article